Item 16. FORM 10-K SUMMARY

None.

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, West Pharmaceutical Services, Inc. has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

WEST PHARMACEUTICAL SERVICES, INC.

(Registrant)

By: /s/ Robert W. McMahon

Robert W. McMahon

Senior Vice President, Chief Financial Officer

February 17, 2026

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of West Pharmaceutical Services, Inc. and in the capacities and on the dates indicated.


Signature	Title	Date
/s/ Eric M. Green	President, Chief Executive Officer and Chair of the Board	February 17, 2026
Eric M. Green	(Principal Executive Officer)

/s/ Robert W. McMahon	Senior Vice President, Chief Financial Officer	February 17, 2026
Robert W. McMahon	(Principal Financial Officer)

/s/ Chad R. Winters	Vice President, Finance & Chief Accounting Officer	February 17, 2026
Chad R. Winters	(Principal Accounting Officer)

/s/ Mark A. Buthman	Director	February 17, 2026
Mark A. Buthman

/s/ William F. Feehery, Ph.D.	Director	February 17, 2026
William F. Feehery, Ph.D.

/s/ Robert F. Friel	Director	February 17, 2026
Robert F. Friel

/s/ Janet B. Haugen	Director	February 17, 2026
Janet B. Haugen

/s/ Thomas W. Hofmann	Director	February 17, 2026
Thomas W. Hofmann

/s/ Molly E. Joseph	Director	February 17, 2026
Molly E. Joseph

/s/ Deborah L.V. Keller	Director	February 17, 2026
Deborah L.V. Keller

/s/ Myla P. Lai-Goldman, M.D.	Director	February 17, 2026
Myla P. Lai-Goldman, M.D.

/s/ Stephen H. Lockhart, M.D., Ph.D.	Director	February 17, 2026
Stephen H. Lockhart, M.D., Ph.D.

/s/ Douglas A. Michels	Director	February 17, 2026
Douglas A. Michels

/s/ Paolo Pucci	Director	February 17, 2026
Paolo Pucci

Previous: Item 15. EXHIBITS AND FINANCIAL STATEMENT SCHEDULES